Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
12.33
-0.31 (-2.45%)
At close: May 29, 2026, 4:00 PM EDT
12.25
-0.08 (-0.65%)
After-hours: May 29, 2026, 7:59 PM EDT

TNXP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1972001452430177
Market Cap Growth
21.53%38.09%512.36%-20.74%-83.20%27.94%
Enterprise Value
12.37-6.753.728.22-90.1-0.77
Last Close Price
12.3315.6232.981289.607796.00228928.00
PS Ratio
11.2015.2414.333.04--
PB Ratio
0.770.811.040.220.140.81
P/TBV Ratio
0.570.540.170.100.070.60
EV/Sales Ratio
0.70-0.515.321.06--
EV/EBITDA Ratio
-0.05--0.810.01
EV/EBIT Ratio
-0.05--0.800.01
EV/FCF Ratio
-0.06--0.620.01
Debt / Equity Ratio
0.000.000.060.090.000.00
Net Debt / Equity Ratio
-0.81-0.84-0.65-0.14-0.58-0.81
Net Debt / EBITDA Ratio
1.231.670.680.131.081.93
Net Debt / FCF Ratio
1.412.001.490.140.821.60
Asset Turnover
0.070.060.060.0400
Inventory Turnover
1.510.920.700.70--
Quick Ratio
6.556.945.601.326.618.23
Current Ratio
6.687.136.062.537.198.71
Return on Equity (ROE)
-19.86%-64.48%-106.12%-74.61%-51.76%-60.25%
Return on Assets (ROA)
-56.51%-57.13%-86.15%-62.28%-48.05%-54.45%
Return on Invested Capital (ROIC)
-369.74%-286.59%-168.62%-117.82%-174.15%-348.98%
Return on Capital Employed (ROCE)
-63.71%-64.31%-97.59%-69.01%-52.54%-60.03%
Buyback Yield / Dilution
-372.88%-1055.90%-9191.34%-334.14%-220.61%-285.23%
Total Shareholder Return
-372.88%-1055.90%-9191.34%-334.14%-220.61%-285.23%
SEC Filings: 10-K · 10-Q